Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics, Inc. (RAPT) Shares Outstanding (Weighted Average) (2020 - 2024)

RAPT Therapeutics' Shares Outstanding (Weighted Average) history spans 4 years, with the latest figure at $38.8 million for Q3 2024.

  • For Q3 2024, Shares Outstanding (Weighted Average) rose 1.15% year-over-year to $38.8 million; the TTM value through Sep 2024 reached $38.8 million, up 1.15%, while the annual FY2023 figure was $38.3 million, 17.82% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q3 2024 was $38.8 million at RAPT Therapeutics, roughly flat from $38.7 million in the prior quarter.
  • Across five years, Shares Outstanding (Weighted Average) topped out at $38.8 million in Q3 2024 and bottomed at $24.8 million in Q1 2021.
  • The 4-year median for Shares Outstanding (Weighted Average) is $32.5 million (2022), against an average of $33.2 million.
  • The largest annual shift saw Shares Outstanding (Weighted Average) increased 29.45% in 2023 before it rose 0.9% in 2024.
  • A 4-year view of Shares Outstanding (Weighted Average) shows it stood at $27.4 million in 2021, then increased by 18.8% to $32.5 million in 2022, then rose by 17.82% to $38.3 million in 2023, then increased by 1.21% to $38.8 million in 2024.
  • Per Business Quant, the three most recent readings for RAPT's Shares Outstanding (Weighted Average) are $38.8 million (Q3 2024), $38.7 million (Q2 2024), and $38.6 million (Q1 2024).